Literature DB >> 17962908

Pneumatosis intestinalis: a variant of bevacizumab related perforation possibly associated with chemotherapy related GI toxicity.

Timothy R Asmis1, Ki Y Chung, Jerrold B Teitcher, David P Kelsen, Manish A Shah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17962908     DOI： 10.1007/s10637-007-9094-z

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN： 0167-6997            Impact factor:   3.850


× No keyword cloud information.
  9 in total

1.  Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab.

Authors:  Frank A Scappaticci; Louis Fehrenbacher; Thomas Cartwright; John D Hainsworth; William Heim; Jordan Berlin; Fairooz Kabbinavar; William Novotny; Somnath Sarkar; Herbert Hurwitz
Journal:  J Surg Oncol       Date:  2005-09-01       Impact factor: 3.454

2.  Gastrointestinal complications of cytosine-arabinoside chemotherapy: findings on plain abdominal radiographs.

Authors:  R T Tjon A Tham; L T Vlasveld; R Willemze
Journal:  AJR Am J Roentgenol       Date:  1990-01       Impact factor: 3.959

3.  VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature.

Authors:  Tomomi Kamba; Betty Y Y Tam; Hiroya Hashizume; Amy Haskell; Barbara Sennino; Michael R Mancuso; Scott M Norberg; Shaun M O'Brien; Rachel B Davis; Lori C Gowen; Keith D Anderson; Gavin Thurston; Shuji Joho; Matthew L Springer; Calvin J Kuo; Donald M McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-19       Impact factor: 4.733

4.  Increased risk of ischemic bowel complications during treatment with bevacizumab after pelvic irradiation: report of three cases.

Authors:  Florian Lordick; Hans Geinitz; Joerg Theisen; Andreas Sendler; Mario Sarbia
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-02-28       Impact factor: 7.038

5.  Pneumatosis cystoides intestinalis after chemotherapy for hematological malignancies: report of 4 cases.

Authors:  S Hashimoto; H Saitoh; K Wada; T Kobayashi; H Furushima; H Kawai; T Shinbo; K Funakoshi; H Takahashi; A Shibata
Journal:  Intern Med       Date:  1995-03       Impact factor: 1.271

Review 6.  Gastrointestinal perforation due to bevacizumab in colorectal cancer.

Authors:  Muhammad Wasif Saif; Aymen Elfiky; Ronald R Salem
Journal:  Ann Surg Oncol       Date:  2007-03-14       Impact factor: 5.344

7.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

Review 8.  Pneumatosis intestinalis: a review.

Authors:  Y Heng; M D Schuffler; R C Haggitt; C A Rohrmann
Journal:  Am J Gastroenterol       Date:  1995-10       Impact factor: 10.864

Review 9.  The spectrum of pneumatosis intestinalis.

Authors:  Shawn D St Peter; Maher A Abbas; Keith A Kelly
Journal:  Arch Surg       Date:  2003-01
  9 in total
  15 in total

Review 1.  What the emergency radiologist needs to know about treatment-related complications from conventional chemotherapy and newer molecular targeted agents.

Authors:  Sona A Chikarmane; Bharti Khurana; Katherine M Krajewski; Atul B Shinagare; Stephanie Howard; Aaron Sodickson; Jyothi Jagannathan; Nikhil Ramaiya
Journal:  Emerg Radiol       Date:  2012-06-07

2.  Colonic pneumatosis and intestinal perforations with sunitinib treatment for renal cell carcinoma.

Authors:  Thomas W Flaig; Fernando J Kim; Francisco G La Rosa; Kathryn Breaker; Jonathan Schoen; Paul D Russ
Journal:  Invest New Drugs       Date:  2008-06-18       Impact factor: 3.850

3.  Pneumatosis intestinalis associated with treatment of cancer patients with the vascular growth factor receptor tyrosine kinase inhibitors sorafenib and sunitinib.

Authors:  Romain Coriat; Stanislas Ropert; Olivier Mir; Bertrand Billemont; Stanislas Chaussade; Pierre-Philippe Massault; Benoit Blanchet; Olivier Vignaux; François Goldwasser
Journal:  Invest New Drugs       Date:  2010-06-05       Impact factor: 3.850

4.  Two cases of bowel perforation associated with sunitinib treatment for renal cell carcinoma.

Authors:  Yoshinori Hoshino; Hirotoshi Hasegawa; Yoshiyuki Ishii; Takashi Endo; Hiroki Ochiai; Koji Okabayashi; Gou Kaneko; Shuji Mikami; Makio Mukai; Mototsugu Oya; Yuko Kitagawa
Journal:  Int J Clin Oncol       Date:  2011-09-17       Impact factor: 3.402

Review 5.  Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer.

Authors:  Rebecca L Stone; Anil K Sood; Robert L Coleman
Journal:  Lancet Oncol       Date:  2010-03-10       Impact factor: 41.316

6.  Imaging features of bowel toxicities in the setting of molecular targeted therapies in cancer patients.

Authors:  E Thornton; S A Howard; J Jagannathan; K M Krajewski; A B Shinagare; K O'Regan; J M Cleary; N H Ramaiya
Journal:  Br J Radiol       Date:  2012-06-06       Impact factor: 3.039

7.  Tumor fistulization associated with targeted therapy: computed tomographic findings and clinical consequences.

Authors:  Henry Chow; Adam Jung; Jason Talbott; Amy M Lin; Adil I Daud; Fergus V Coakley
Journal:  J Comput Assist Tomogr       Date:  2011 Jan-Feb       Impact factor: 1.826

Review 8.  Pneumatosis intestinalis during chemotherapy with nilotinib in a patient with chronic myeloid leukemia who tested positive for anti-topoisomerase I antibodies.

Authors:  Akihito Fujimi; Hiroki Sakamoto; Yuji Kanisawa; Shinya Minami; Yasuhiro Nagamachi; Naofumi Yamauchi; Soushi Ibata; Junji Kato
Journal:  Clin J Gastroenterol       Date:  2016-09-16

9.  Pneumatosis intestinalis and portal venous gas secondary to Gefitinib therapy for lung adenocarcinoma.

Authors:  Joo Young Lee; Hye-Suk Han; Sung-Nam Lim; Young Kwang Shim; Yong Hyeok Choi; Ok-Jun Lee; Ki Hyeong Lee; Seung Taik Kim
Journal:  BMC Cancer       Date:  2012-03-10       Impact factor: 4.430

Review 10.  Imaging of complications of oncological therapy in the gastrointestinal system.

Authors:  Chitra Viswanathan; Priya Bhosale; Dhakshin Moorthy Ganeshan; Myelene T Truong; Paul Silverman; Aparna Balachandran
Journal:  Cancer Imaging       Date:  2012-05-07       Impact factor: 3.909
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.